| Title: |
A Phase II Study of Neoadjuvant Opnurasib KRAS G12C Inhibitor in Patients With Surgically Resectable Non-Small Cell Lung Cancer (CCTG IND.242A): A Substudy of the IND.242 Platform Master Protocol |
| Authors: |
Spicer, J.; Blais, N.; Owen, S.; Robinson, A.G.; Chu, Q.; Labbe, C.; Shieh, B.; Brown-Walker, P.; Sederias, J.; Jensen, K.; Farago, A.F.; Tsao, M.-S.; Cottrell, T.R.; Kidane, B.; Laurie, S.; Juergens, R.; Bradbury, P.A.; Tu, W.; Gaudreau, P.-O. |
| Contributors: |
Novartis; Novartis Pharmaceuticals Canada Inc; Canadian Cancer Society Research Institute |
| Source: |
Clinical Lung Cancer ; volume 26, issue 2, page 146-151 ; ISSN 1525-7304 |
| Publisher Information: |
Elsevier BV |
| Publication Year: |
2025 |
| Collection: |
ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| DOI: |
10.1016/j.cllc.2024.09.003 |
| Availability: |
https://doi.org/10.1016/j.cllc.2024.09.003; https://api.elsevier.com/content/article/PII:S1525730424001980?httpAccept=text/xml; https://api.elsevier.com/content/article/PII:S1525730424001980?httpAccept=text/plain |
| Rights: |
https://www.elsevier.com/tdm/userlicense/1.0/ ; https://www.elsevier.com/legal/tdmrep-license ; http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| Accession Number: |
edsbas.C63880A7 |
| Database: |
BASE |